scholarly journals A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)

2006 ◽  
Vol 17 (7) ◽  
pp. 1111-1119 ◽  
Author(s):  
R. Booton ◽  
P. Lorigan ◽  
H. Anderson ◽  
S. Baka ◽  
L. Ashcroft ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document